Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Non-Current Deffered Revenue (2019 - 2021)

INVO Fertility has reported Non-Current Deffered Revenue over the past 3 years, most recently at $2.3 million for Q3 2021.

  • Quarterly Non-Current Deffered Revenue fell 23.53% to $2.3 million in Q3 2021 from the year-ago period, while the trailing twelve-month figure was $2.3 million through Sep 2021, down 23.53% year-over-year, with the annual reading at $2.9 million for FY2020, 20.0% down from the prior year.
  • Non-Current Deffered Revenue was $2.3 million for Q3 2021 at INVO Fertility, down from $2.5 million in the prior quarter.
  • Over five years, Non-Current Deffered Revenue peaked at $3.9 million in Q2 2019 and troughed at $2.3 million in Q3 2021.
  • The 3-year median for Non-Current Deffered Revenue is $3.1 million (2020), against an average of $3.1 million.
  • Year-over-year, Non-Current Deffered Revenue dropped 18.18% in 2020 and then fell 23.53% in 2021.
  • A 3-year view of Non-Current Deffered Revenue shows it stood at $3.6 million in 2019, then decreased by 20.0% to $2.9 million in 2020, then dropped by 18.75% to $2.3 million in 2021.
  • Per Business Quant, the three most recent readings for IVF's Non-Current Deffered Revenue are $2.3 million (Q3 2021), $2.5 million (Q2 2021), and $2.7 million (Q1 2021).